Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Breaking out, (.47/.50) looking very promi

<< Previous

Bullboard Posts

Next >>

Comment by BILLMINERon Feb 09, 2011 2:20pm

276 Views

Post# 18103363

RE: RE: Breaking out, (.47/.50) looking very promi

I would bet that the reason behind the buying today is good visuals in the core. Perhaps a great hole or many. As Lynda said, it could be a "game changer" if they hit in bewteen the two deposits.
jmo

<< Previous

Bullboard Posts

Next >>

Michael Gentile tops up stake in Astra Exploration